2-hydroxyamino-1-methyl-6-phenylimidazo(4,5-b)pyridine has been researched along with Adenocarcinoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
De Marzo, AM; Groopman, JD; Isaacs, WB; Kensler, TW; Kidd, LC; Nelson, CP; Nelson, WG; Sauvageot, J | 1 |
1 other study(ies) available for 2-hydroxyamino-1-methyl-6-phenylimidazo(4,5-b)pyridine and Adenocarcinoma
Article | Year |
---|---|
Protection against 2-hydroxyamino-1-methyl-6-phenylimidazo[4,5-b]pyridine cytotoxicity and DNA adduct formation in human prostate by glutathione S-transferase P1.
Topics: Adenocarcinoma; Aged; Biotransformation; Carcinogens; Cytosol; DNA; DNA Adducts; Glutathione S-Transferase pi; Glutathione Transferase; Humans; Imidazoles; Isoenzymes; Male; Middle Aged; Prostate; Prostatic Neoplasms; Pyridines; Transfection; Tumor Cells, Cultured | 2001 |